跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TIGECICLINA HIKMA 50 MG POLVO PARA SOLUCION PARA PERFUSION EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
TIGECICLINA HIKMA 50 MG POLVO PARA SOLUCION PARA PERFUSION EFG
Approved
STANDARD
TIGECICLINA HIKMA 50 MG POLVO PARA SOLUCION PARA PERFUSION EFG
Hikma Farmaceutica (Portugal) S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Oct 21, 2022
Approval ID
531ca49eb69f9c96
Company
Hikma Farmaceutica (Portugal) S.A.
Type
Standard
Approval Details
Approval Id
531ca49eb69f9c96
Drug Cima Aemps Name
TIGECICLINA HIKMA 50 MG POLVO PARA SOLUCION PARA PERFUSION EFG
Register Number
88216
Holder Company Name
Hikma Farmaceutica (Portugal) S.A.
Marketing Company Name
Hikma España, S.L.U.
Holder Company Detail Path
/organization/hikma-farmaceutica-portugal-s-a
Authorization Date
2022-10-21
Dosage Form
POLVO PARA SOLUCIÓN PARA PERFUSIÓN
Dose
50 mg
Route Of Administration
VÍA INTRAVENOSA
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Hikma Farmaceutica (Portugal) S.A.
Company Detail Path
/organization/hikma-farmaceutica-portugal-s-a
Company Information
Pharmaceutical Company Name
HIKMA FARMACÊUTICA (PORTUGAL), S.A.
Country Name
Portugal
City Name
terrugem snt,lisboa,country_pt
Address
ESTRADA RIO DA MÓ, 8/8A/B
Active Ingredients
TIGECICLINA
50 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Oct 21, 2022
Approval ID
531ca49eb69f9c96
Type
Standard
Back to CIMA-AEMPS Approvals